The Ministry of Health (MoH) of the Republic of Trinidad and Tobago has issued an alert regarding falsified IBRANCE (palbociclib) capsules, a medicine used in treating specific types of breast cancer. The Ministry’s Chemistry, Food and Drugs Division (CFDD) has advised the public about a WHO alert concerning these counterfeit products. The fake products misrepresent their origins, composition, and identity. Pfizer, the original manufacturer, has confirmed the falsified nature of these products. These counterfeit medicines have been detected in Côte d’Ivoire, Egypt, Lebanon, Libya, and Türkiye. The falsified capsules contain no active pharmaceutical ingredient, making them unsafe for consumption. Using these can lead to treatment failure, uncontrolled cancer progression, and a higher risk of death. The Ministry advises individuals who might have these drugs to stop using them immediately and return them to the place of purchase. The counterfeit products display multiple packaging discrepancies and capsule irregularities.
Join the Trinidad and Tobago WhatsApp update group: https://chat.whatsapp.com/DKueX7ZV35626FbOsKBt03
PM Persad-Bissessar Shares Behind-The-Scenes Message Minutes Before Addressing United Nations General Assembly
Trinidad Creator Questions Whether Growing Plaza Culture Could Slowly Kill Traditional Downtown Shopping Districts
Paralysed Man Reveals Why He Forgave Partner Who Cheated With Someone He Called Brother
Shamfa Cudjoe-Lewis urges Tobagonians to examine Special Operations Bill and its potential impact closely
Pundit responds after woman raises concerns over murtis left inside the Valencia River following ceremony
Stuart Young Warns Procurement Bill Could Weaken OPR, Calls It ‘Section 34 On Steroids’